1.
Drobna-Śledzińska M, Maćkowska-Maślak N, Jaksik R, Fijałkowski I, Kosmalska M, Czarny J, Lejman M, Sędek Łukasz, Szczepański T, Pastorczak A, Derwich K, Witt M, Ntziachristos P, Dawidowska M. KSR2 is a novel oncogene in TAL1 subtype of T-cell acute lymphoblastic leukemia with potential clinical and prognostic implications. haematol [Internet]. 2020Sep.10 [cited 2026Aug.15];. Available from: https://haematologica.org/article/view/14338